David R.P. Almeida, MD, MBA, PhD, FRCSC, DABO, is a highly accomplished vitreoretinal surgeon and researcher with extensive experience in ophthalmic and vitreoretinal studies. As President and CEO of Erie Retina Research and The Centers for Advanced Surgical Exploration (CASEx), Dr. Almeida leads innovative clinical research initiatives across multiple international sites.
Dr. Almeida’s academic background includes an Honors Bachelor of Science from the University of Toronto, a PhD in pharmaceutical research from the University of Szeged, and an MBA in healthcare management from the George Washington University. He completed his ophthalmology residency at Queen’s University and a fellowship in vitreoretinal diseases and surgery at the University of Iowa.
With over 300 peer-reviewed publications and more than 250 presentations at major conferences, Dr. Almeida is a recognized thought leader in his field. His research interests span age-related macular degeneration, diabetic eye disease, complex surgery, and practice efficiency. As Principal Investigator, he has led over 80 clinical trials across all phases of development on three continents.
Dr. Almeida’s leadership extends beyond his clinical practice. He serves as President of Erie Eye Research and Chairman of the Board of Directors for ACCESS FOR ALL (nonprofit). His role as Chief Technology Officer for SurgTech.AI demonstrates his commitment to advancing technological innovations in ophthalmology.
Recognized for his expertise, Dr. Almeida has received numerous awards, including the American Society of Retina Specialists (ASRS) Honor Award and has been named to The Ophthalmologist Power List Top 50 Rising Stars in Ophthalmology. His unique clinical expertise, research acumen, and business insight make him an invaluable asset to complex research and development programs.